A significant breakthrough in new coating technology is now available from Specialty Coating Systems (SCS). SCS microRESIST Antimicrobial Parylene Technology combines antimicrobial properties with the benefits of biocompatible Parylene to effectively reduce harmful microorganisms on coated medical devices.
Catheters, electrostimulators, endotracheal tubes and other medical devices, where antimicrobial properties are critical during a product’s use, can now be applied with SCS microRESIST.
Hospitals and health care providers have been looking for solutions to the ongoing and increasing challenge to cross-transmission of problematic pathogens, which cause healthcare-associated infections (HAIs). They have been increasingly interested in antimicrobial protection for devices, which are in continuous contact with patients. SCS has been dedicated to developing a solution to assist health care providers and manufacturers in their response to the rising number of HAIs and, as a result, introduced SCS microRESIST Antimicrobial Parylene Technology.
SCS microRESIST-coated samples were tested for antimicrobial activity according to JIS Z 2801 standard. The new Parylene technology was tested against 14 of the most common microorganisms and achieved greater than Log 5 reduction after 24 hours. microRESIST was tested for long-term effectiveness against E. coli and achieved greater than Log 5 reduction after 7 and 15 days.
For more information about SCS microRESIST Antimicrobial Parylene Technology, please visit scscoatings.com/microRESIST or contact Juan Gudino at 317.244.1200, ext. 229.